Harpoon Therapeutics to Participate in the Piper Sandler 34th Annual Healthcare Conference
November 21 2022 - 04:59PM
Harpoon Therapeutics, Inc. (NASDAQ: HARP), a clinical-stage
immunotherapy company developing novel T cell engagers, today
announced that management will participate in a fireside chat at
the Piper Sandler 34th Annual Healthcare Conference. The discussion
will take place on Wednesday, November 30, 2022 at 1:00 p.m. ET
(10:00 a.m. PT).
A live audio webcast of the fireside chat will be available in
the Investors section of the Harpoon Therapeutics website at
www.harpoontx.com with an archived replay available following the
event.
About Harpoon Therapeutics
Harpoon Therapeutics is a clinical-stage immunotherapy company
developing a novel class of T cell engagers that harness the power
of the body’s immune system to treat patients suffering from cancer
and other diseases. T cell engagers are engineered proteins that
direct a patient’s own T cells to kill target cells that express
specific proteins, or antigens, carried by the target cells. Using
its proprietary Tri-specific T cell Activating Construct (TriTAC®)
platform, Harpoon is developing a pipeline of novel TriTACs
initially focused on the treatment of solid tumors and hematologic
malignancies. Harpoon has also developed a proprietary ProTriTAC™
platform, which applies a prodrug concept to its TriTAC platform to
create a therapeutic T cell engager that remains inactive until it
reaches the tumor. Harpoon’s third proprietary technology platform,
extended release TriTAC-XR, is designed to mitigate cytokine
release syndrome. For additional information about Harpoon
Therapeutics, please visit www.harpoontx.com.
Contacts:
ICR Westwicke:Robert H. UhlManaging
Director858-356-5932robert.uhl@westwicke.com
Media:uncapped
Communications512-825-2603megan.russell@uncappedcommunications.com
Harpoon Therapeutics (NASDAQ:HARP)
Historical Stock Chart
From Feb 2024 to Mar 2024
Harpoon Therapeutics (NASDAQ:HARP)
Historical Stock Chart
From Mar 2023 to Mar 2024